Stem cell treatment offers hope for newborns with brain damage
Oxygen deprivation around birth can lead to brain damage in babies, with far-reaching consequences. A new stem cell treatment administered via nasal drops is showing promising results. In a safety study conducted at UMC Utrecht, called PASSIoN, ten newborns received this ‘intranasal stem cell therapy’ shortly after birth.
Most of the children showed remarkably positive development: they started walking earlier on average than untreated children with comparable brain damage, had no motor impairments, and none developed epilepsy or visual problems. The study results were published today in the scientific journal Stroke.